This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
OIG defined speaker programs as drug or device “company-sponsored events at which a [outside] physician or other healthcare professional (collectively, “HCP”) makes a speech or presentation to other [outside] HCPs about a drug or device product or a disease state on behalf of the company” using a presentation developed and approved by the company.
By Eduardo Arenas Catalán The Principles and Guidelines on Human Rights and Public Health Emergencies (the Principles), entail a notable attempt to consolidate lessons learned from the COVID-19 pandemic. by requiring barriers like intellectual property to be human rights compliant; Principle 27.2(a),
By Jon Larsen and Sterling Johnson People who need opioid use (OUD) treatment in the United States are often not receiving it — at least two million people with OUD are experiencing a treatment gap that prevents or hampers their ability to receive life-saving care and support.
If one red stripe appears on the strip, fentanyl is present; two stripes mean none of that drug is found. Many of the participants who tried the strips, Marshall said, discarded the substance if fentanyl was present, used the drug with someone else present, or had naloxone available during use.
This essay describes the cost of casting aside what is best for the public’s health in favor of individual choice, especially to those who are high-risk for serious illness or death from COVID-19. It explores how they must negotiate public health measures on their own. In other words, public health is a group project.
Since markets are inherently individualistic and the basic unit of analysis of public health is the community, this ideology was and is antithetical to our goals. After initial disputes and over time, they will gain followers if such requirements are presented as morally required. Should we have seen this coming? Absolutely.
The latest (March 2021) Kaiser Family Foundation Tracking Poll learned that at least one in three Americans were recently “struggling” to pay living expenses since December 2020, with six in ten families affected by COVID-19 having lost a job or income. That is immediate “rescue” funding for the short-term.
COVID-19 will be with us — in our society and in our brains — for the foreseeable future. This symposium contribution focuses specifically on COVID’s lasting effects in our brains, about which much is still unknown. What does COVID infection do to our brains? By Emily R.D.
Becerra is mostly read as a religious freedom case that pits the Religious Freedom Restoration Act (RFRA) against the promotion of public health goals, similar to what we saw in the last few years of legal challenges to COVID-19 mitigation measures.
NATIONAL AHA, others oppose PhRMA-led campaign to restrict 340B eligibility AHA case studies feature hospitals that integrate physical and behavioral health services As birth rates increase, OB-GYN shortage worsens Biden, divided Congress seek common ground on healthcarereforms CMS resumes all No Surprises Act payment determinations FTC highlights (..)
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content